BRPI0509805A - processos de tratamento de carcinoma hepatocelular com denspm - Google Patents

processos de tratamento de carcinoma hepatocelular com denspm

Info

Publication number
BRPI0509805A
BRPI0509805A BRPI0509805-0A BRPI0509805A BRPI0509805A BR PI0509805 A BRPI0509805 A BR PI0509805A BR PI0509805 A BRPI0509805 A BR PI0509805A BR PI0509805 A BRPI0509805 A BR PI0509805A
Authority
BR
Brazil
Prior art keywords
hepatocellular carcinoma
denspm
treatment processes
carcinoma treatment
methods
Prior art date
Application number
BRPI0509805-0A
Other languages
English (en)
Inventor
David Davidson
Raymond Bergeron
Original Assignee
Genzyme Corp
Univ Florida Res Foudantion In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Univ Florida Res Foudantion In filed Critical Genzyme Corp
Publication of BRPI0509805A publication Critical patent/BRPI0509805A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCESSOS DE TRATAMENTO DE CARCINOMA HEPATOCELULAR COM DENSPM. A presente invenção refere-se a processos para o tratamento de carcinoma hepatocelular. Os processos incluem a administração a um sujeito de uma quantidade eficaz de DENSPM para tratar o carcinoma hepatocelular.
BRPI0509805-0A 2004-04-12 2005-04-12 processos de tratamento de carcinoma hepatocelular com denspm BRPI0509805A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56143804P 2004-04-12 2004-04-12
PCT/US2005/012039 WO2005099723A1 (en) 2004-04-12 2005-04-12 Methods of treating hepatocellular carcinoma with denspm

Publications (1)

Publication Number Publication Date
BRPI0509805A true BRPI0509805A (pt) 2007-09-18

Family

ID=34966078

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509805-0A BRPI0509805A (pt) 2004-04-12 2005-04-12 processos de tratamento de carcinoma hepatocelular com denspm

Country Status (8)

Country Link
US (1) US20070167528A1 (pt)
EP (1) EP1755621A1 (pt)
JP (1) JP2007532574A (pt)
KR (1) KR20070011453A (pt)
CN (1) CN1942195A (pt)
BR (1) BRPI0509805A (pt)
MX (1) MXPA06011488A (pt)
WO (1) WO2005099723A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342945A (en) * 1986-12-02 1994-08-30 University Of Florida Research Foundation, Inc. Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5091596A (en) * 1990-12-20 1992-02-25 Univ. Of Va. Alumni Patents Foundation Method for producing chiro-inositol
WO2000006136A2 (en) * 1998-07-31 2000-02-10 The Health Research, Inc. Therapeutic combination of polyamine with an anticancer agent

Also Published As

Publication number Publication date
CN1942195A (zh) 2007-04-04
EP1755621A1 (en) 2007-02-28
MXPA06011488A (es) 2007-03-21
JP2007532574A (ja) 2007-11-15
WO2005099723A1 (en) 2005-10-27
US20070167528A1 (en) 2007-07-19
KR20070011453A (ko) 2007-01-24

Similar Documents

Publication Publication Date Title
EA200801897A1 (ru) Ингибиторы mnk2 на основе 8-гетероарилпурина для лечения метаболических нарушений
EA201000603A1 (ru) ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ
UY32030A (es) "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0519424A2 (pt) composiÇÕes e mÉtodos para tratamento de distérbios de proliferaÇço celular
EA201300522A1 (ru) Фармацевтические комбинации для лечения метаболических нарушений
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
EA201071243A1 (ru) Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом
BRPI0510094A (pt) uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos
EA201000914A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
EA201370208A1 (ru) Формы рифаксимина и их применение
EA201270184A1 (ru) Лечение расстройств печени ингибиторами pi3k
EA201490748A1 (ru) Лечение рассеянного склероза комбинацией лахинимода и финголимода
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
WO2015054619A8 (en) Use of a pcsk9 inhibitor to treat hyperlipidemia
EA201101117A1 (ru) Ингибиторы дпп-4 для лечения диабета у детей
BR112015005117A2 (pt) métodos de tratamento da doença de alzheimer e suas composições farmacêuticas
EA201690745A1 (ru) Способы лечения и предотвращения болезни "трансплантат против хозяина"
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA200601746A1 (ru) Применение ротиготина для лечения и предупреждения синдрома "паркинсонизм-плюс"
EA201000673A1 (ru) СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ ИЗМЕРЕНИЯ АКТИВАЦИИ Wnt И ДЛЯ ЛЕЧЕНИЯ Wnt-ОПОСРЕДОВАННЫХ РАКОВЫХ ЗАБОЛЕВАНИЙ
EA202192122A1 (ru) Соединения, обладающие активностью индуцирования ферроптоза, и способы их применения
MX2015013948A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
DE602006012013D1 (de) Proteasom-hemmer und verwendungsverfahren dafür
BR112015026297A2 (pt) terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer
BR112014019399A2 (pt) métodos de tratamento da fibrose

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]